Jennifer McClure to Quinoxalines
This is a "connection" page, showing publications Jennifer McClure has written about Quinoxalines.
Connection Strength
1.109
-
Smoking outcome by psychiatric history after behavioral and varenicline treatment. J Subst Abuse Treat. 2010 Jun; 38(4):394-402.
Score: 0.358
-
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. J Gen Intern Med. 2009 May; 24(5):563-9.
Score: 0.332
-
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J. 2012 Aug; 12(4):349-58.
Score: 0.097
-
Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011 May; 13(5):361-8.
Score: 0.095
-
Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med. 2010 May; 38(5):482-90.
Score: 0.090
-
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat. 2009 Jun; 36(4):428-34.
Score: 0.081
-
Organic cation transporter variation and response to smoking cessation therapies. Nicotine Tob Res. 2014 Dec; 16(12):1638-46.
Score: 0.030
-
Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res. 2011 May; 13(5):319-27.
Score: 0.024